Transforming orthopaedics and regenerative medicine through pioneering use of nanoclay gels stemming from world-class stem cell research
Renovos is an exciting opportunity for bioscience investors who share our vision of innovation in the regenerative medicine space.
Our motivation is to unlock the full potential of regenerative medicine with our innovative Renovite® nanoclay gel technology platform, and help clinicians deliver more efficacious treatments for tissue repair without side-effects.
Growing market and need
$17bn
spinal fusion and foot and ankle markets by 2022
>3m
spinal fusion procedures worldwide every year
>$5bn